skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 3,383  for All Library Resources

Results 1 2 3 4 5 next page
Refined by: subject: Diabetes remove subject: Male remove subject: Risk Factors remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Ticagrelor with or without Aspirin in High-Risk Patients after PCI
Material Type:
Article
Add to My Research

Ticagrelor with or without Aspirin in High-Risk Patients after PCI

The New England journal of medicine, 2019-11, Vol.381 (21), p.2032-2042 [Peer Reviewed Journal]

Copyright © 2019 Massachusetts Medical Society. All rights reserved. ;Copyright © 2019 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1908419 ;PMID: 31556978

Full text available

2
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
Material Type:
Article
Add to My Research

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

The Lancet (British edition), 2019-07, Vol.394 (10193), p.121-130 [Peer Reviewed Journal]

2019 Elsevier Ltd ;Copyright © 2019 Elsevier Ltd. All rights reserved. ;2019. Elsevier Ltd ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(19)31149-3 ;PMID: 31189511

Full text available

3
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
Material Type:
Article
Add to My Research

Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes

The New England journal of medicine, 2016-07, Vol.375 (4), p.323-334 [Peer Reviewed Journal]

Copyright © 2016 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1515920 ;PMID: 27299675

Full text available

4
Variation in PCSK9 and HMGCR and Risk of Cardiovascular Disease and Diabetes
Material Type:
Article
Add to My Research

Variation in PCSK9 and HMGCR and Risk of Cardiovascular Disease and Diabetes

The New England journal of medicine, 2016-12, Vol.375 (22), p.2144-2153 [Peer Reviewed Journal]

Copyright © 2016 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1604304 ;PMID: 27959767

Full text available

5
Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication
Material Type:
Article
Add to My Research

Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication

Diabetes care, 2020-07, Vol.43 (7), p.1399-1407 [Peer Reviewed Journal]

2020 by the American Diabetes Association. ;Copyright American Diabetes Association Jul 1, 2020 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc20-0660 ;PMID: 32409498

Full text available

6
Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol
Material Type:
Article
Add to My Research

Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol

The New England journal of medicine, 2020-04, Vol.382 (16), p.1507-1519 [Peer Reviewed Journal]

Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1912387 ;PMID: 32187462

Full text available

7
Healthy lifestyle and life expectancy free of cancer, cardiovascular disease, and type 2 diabetes: prospective cohort study
Material Type:
Article
Add to My Research

Healthy lifestyle and life expectancy free of cancer, cardiovascular disease, and type 2 diabetes: prospective cohort study

BMJ (Online), 2020-01, Vol.368, p.l6669-l6669 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions 2020 BMJ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to 2020 BMJ ;ISSN: 1756-1833 ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.l6669 ;PMID: 31915124

Full text available

8
Can machine-learning improve cardiovascular risk prediction using routine clinical data?
Material Type:
Article
Add to My Research

Can machine-learning improve cardiovascular risk prediction using routine clinical data?

PloS one, 2017-04, Vol.12 (4), p.e0174944-e0174944 [Peer Reviewed Journal]

COPYRIGHT 2017 Public Library of Science ;COPYRIGHT 2017 Public Library of Science ;2017 Weng et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2017 Weng et al 2017 Weng et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0174944 ;PMID: 28376093

Full text available

9
High prevalence of erectile dysfunction in diabetes: a systematic review and meta-analysis of 145 studies
Material Type:
Article
Add to My Research

High prevalence of erectile dysfunction in diabetes: a systematic review and meta-analysis of 145 studies

Diabetic medicine, 2017-09, Vol.34 (9), p.1185 [Peer Reviewed Journal]

2017 Diabetes UK. ;EISSN: 1464-5491 ;DOI: 10.1111/dme.13403 ;PMID: 28722225

Digital Resources/Online E-Resources

10
Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Material Type:
Article
Add to My Research

Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes

The New England journal of medicine, 2018-08, Vol.379 (7), p.633-644 [Peer Reviewed Journal]

Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1800256 ;PMID: 30110583

Full text available

11
Association of diabetic foot ulcer and death in a population-based cohort from the United Kingdom
Material Type:
Article
Add to My Research

Association of diabetic foot ulcer and death in a population-based cohort from the United Kingdom

Diabetic medicine, 2016-11, Vol.33 (11), p.1493-1498 [Peer Reviewed Journal]

2015 Diabetes UK ;2015 Diabetes UK. ;Diabetic Medicine © 2016 Diabetes UK ;ISSN: 0742-3071 ;EISSN: 1464-5491 ;DOI: 10.1111/dme.13054 ;PMID: 26666583 ;CODEN: DIMEEV

Full text available

12
Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies
Material Type:
Article
Add to My Research

Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies

The Lancet (British edition), 2018-04, Vol.391 (10129), p.1513-1523 [Peer Reviewed Journal]

2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. ;Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;Copyright Elsevier Limited Apr 14, 2018 ;info:eu-repo/semantics/openAccess ;Distributed under a Creative Commons Attribution 4.0 International License ;2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. 2018 ;Wageningen University & Research ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(18)30134-X ;PMID: 29676281

Full text available

13
Ultra-processed food intake and risk of cardiovascular disease: prospective cohort study (NutriNet-Santé)
Material Type:
Article
Add to My Research

Ultra-processed food intake and risk of cardiovascular disease: prospective cohort study (NutriNet-Santé)

BMJ, 2019-05, Vol.365 (365), p.l1451-l1451 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions 2019 BMJ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Attribution - NonCommercial ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to 2019 BMJ ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;EISSN: 1468-5833 ;DOI: 10.1136/bmj.l1451 ;PMID: 31142457

Full text available

14
Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial
Material Type:
Article
Add to My Research

Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial

The Lancet (British edition), 2017-10, Vol.390 (10106), p.1962-1971 [Peer Reviewed Journal]

2017 Elsevier Ltd ;Copyright © 2017 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Oct 28, 2017 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(17)32290-0 ;PMID: 28859947

Full text available

15
Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial
Material Type:
Article
Add to My Research

Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial

The Lancet (British edition), 2018-09, Vol.392 (10152), p.1036-1046 [Peer Reviewed Journal]

2018 Elsevier Ltd ;Copyright © 2018 Elsevier Ltd. All rights reserved. ;2018. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(18)31924-X ;PMID: 30158069

Full text available

16
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Material Type:
Article
Add to My Research

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

The New England journal of medicine, 2015-11, Vol.373 (22), p.2117-2128 [Peer Reviewed Journal]

Copyright © 2015 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1504720 ;PMID: 26378978

Full text available

17
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial
Material Type:
Article
Add to My Research

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

The Lancet (British edition), 2019-07, Vol.394 (10193), p.131-138 [Peer Reviewed Journal]

2019 Elsevier Ltd ;Copyright © 2019 Elsevier Ltd. All rights reserved. ;2019. Elsevier Ltd ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(19)31150-X ;PMID: 31189509

Full text available

18
Genomic Risk Prediction of Coronary Artery Disease in 480,000 Adults: Implications for Primary Prevention
Material Type:
Article
Add to My Research

Genomic Risk Prediction of Coronary Artery Disease in 480,000 Adults: Implications for Primary Prevention

Journal of the American College of Cardiology, 2018-10, Vol.72 (16), p.1883-1893 [Peer Reviewed Journal]

Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Oct 16, 2018 ;2018 The Authors 2018 ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2018.07.079 ;PMID: 30309464

Full text available

19
Excess Mortality among Persons with Type 2 Diabetes
Material Type:
Article
Add to My Research

Excess Mortality among Persons with Type 2 Diabetes

The New England journal of medicine, 2015-10, Vol.373 (18), p.1720-1732 [Peer Reviewed Journal]

Copyright © 2015 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1504347 ;PMID: 26510021

Full text available

20
Physical activity trajectories and mortality: population based cohort study
Material Type:
Article
Add to My Research

Physical activity trajectories and mortality: population based cohort study

BMJ (Online), 2019-06, Vol.365, p.l2323-l2323 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions 2019 BMJ This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to 2019 BMJ ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.l2323 ;PMID: 31243014

Full text available

Results 1 - 20 of 3,383  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

New Records 

  1. New From Last 3 Month  (9)
  2. More options open sub menu

Subject 

  1. Humans  (3,374)
  2. Science & Technology  (3,259)
  3. Female  (3,190)
  4. Middle Aged  (2,659)
  5. Life Sciences & Biomedicine  (2,473)
  6. Aged  (2,077)
  7. Adult  (1,849)
  8. Cardiovascular Disease  (1,607)
  9. Diabetes Mellitus  (1,390)
  10. Hypertension  (1,186)
  11. Mortality  (1,094)
  12. Studies  (1,015)
  13. Cardiovascular Diseases  (998)
  14. Health Risks  (941)
  15. Body Mass Index  (931)
  16. Population  (825)
  17. More options open sub menu

Language 

  1. Japanese  (502)
  2. Portuguese  (7)
  3. Norwegian  (6)
  4. French  (2)
  5. German  (2)
  6. Persian  (1)
  7. Chinese  (1)
  8. More options open sub menu

Searching Remote Databases, Please Wait